Testing for autoimmune disease typically starts with blood work that measures inflammation and checks for antibodies attacking your own tissues. There’s no single test that confirms or rules out autoimmune disease across the board. Instead, doctors use a combination of screening tests, specific antibody panels, and sometimes imaging or biopsies to narrow down which of the 80-plus autoimmune conditions might be causing your symptoms. The process takes an average of 4 years and 4 doctors before patients receive a proper diagnosis, according to a survey by the Autoimmune Association.
The ANA Test: Where Most Screening Begins
The antinuclear antibody (ANA) test is usually the first blood test ordered when autoimmune disease is suspected. It detects antibodies that target structures inside your own cells. The test result comes back as a titer, which is a measure of how much the blood sample can be diluted before the antibodies become undetectable. Common titers include 1:40, 1:80, 1:160, and higher.
A positive ANA doesn’t mean you have an autoimmune disease. Up to 30% of healthy people test positive at a titer of 1:40 or greater, and roughly 20% of healthy adults have a positive ANA overall. For lupus classification, the current diagnostic criteria require an ANA of at least 1:80 before other testing even begins. Higher titers and the presence of symptoms together make an autoimmune diagnosis more likely, but a low positive ANA in someone feeling fine is often meaningless.
When the ANA comes back positive, the lab also reports a fluorescence pattern that offers clues about which disease may be involved. A homogeneous pattern, where the entire cell nucleus lights up, points toward lupus or mixed connective tissue disease. A speckled pattern is less specific and can show up in lupus, rheumatoid arthritis, Sjögren’s syndrome, scleroderma, or polymyositis. A nucleolar pattern suggests polymyositis or scleroderma. These patterns help guide the next round of more targeted testing.
Inflammation Markers: CRP and ESR
Two common blood tests measure general inflammation in your body: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Neither test can tell your doctor where inflammation is happening or what’s causing it, but both help establish whether your immune system is in an active state. CRP tends to respond faster than ESR because it’s produced by the liver within hours of inflammation or infection starting, making it more useful for tracking sudden changes.
These tests are often ordered alongside antibody testing. They’re also used later to monitor flares and check whether treatment is working. One important caveat: a normal CRP doesn’t always rule out active inflammation. In lupus patients, for instance, CRP can stay low even during a flare.
Specific Antibody Panels for Targeted Diagnosis
Once a screening test like ANA comes back positive, doctors typically order more specific antibody panels to identify which autoimmune condition is at play. The extractable nuclear antigen (ENA) panel checks for four to six antibodies, each linked to particular diseases. Anti-SSA (also called anti-Ro) antibodies are associated with Sjögren’s syndrome and lupus, and sometimes appear in scleroderma and inflammatory muscle diseases. Anti-SSB (anti-La) antibodies also point toward Sjögren’s syndrome and lupus.
For lupus specifically, two antibodies carry significant diagnostic weight: anti-double-stranded DNA (anti-dsDNA) and anti-Smith antibodies. Under the current classification system used by rheumatologists, testing positive for either one contributes heavily toward a lupus diagnosis, alongside clinical symptoms like joint involvement, skin rashes, kidney problems, or blood count abnormalities. A patient needs a combined score of 10 or more across clinical and lab findings to be formally classified as having lupus.
Rheumatoid Arthritis: RF and Anti-CCP
Two key blood tests help diagnose rheumatoid arthritis. Rheumatoid factor (RF) has been used for decades and picks up about 92% of RA cases, but it also flags positive in people with other conditions or even some healthy individuals, with a specificity of around 74%. The anti-cyclic citrullinated peptide (anti-CCP) test is more precise. It catches about 88% of RA cases while correctly ruling it out about 90% of the time. Many doctors order both tests together, which improves overall accuracy to roughly 90% across the board.
If you have joint pain and stiffness, particularly in the small joints of your hands and feet, and these tests come back positive alongside elevated inflammation markers, the picture becomes fairly clear. But some people with RA test negative on both, a condition called seronegative rheumatoid arthritis, which requires diagnosis based on symptoms and imaging instead.
Thyroid Autoimmune Testing
Autoimmune thyroid conditions have their own set of antibody tests, separate from the ANA panel. For Hashimoto’s thyroiditis, the primary marker is thyroid peroxidase antibodies (TPOAb). A high level of TPOAb combined with elevated TSH (the hormone that rises when your thyroid is underperforming) strongly suggests Hashimoto’s. Thyroglobulin antibodies (TgAb) can also indicate Hashimoto’s disease.
Graves’ disease, which causes an overactive thyroid, is identified through a different antibody: thyroid-stimulating immunoglobulin (TSI). Another test, TSH receptor antibodies (TRAb), is also associated with Graves’ disease. About 95% of people with Graves’ disease have elevated TRAb levels. In the rare cases where someone has Graves’ symptoms but negative antibody results, a thyroid scan can confirm the diagnosis.
Celiac Disease Screening
Celiac disease has one of the more straightforward testing pathways. The tissue transglutaminase IgA (tTG-IgA) test is the standard first step, with sensitivity ranging from 78% to 100% and specificity from 90% to 100%. You need to be eating gluten regularly for the test to work. If you’ve already cut gluten from your diet, antibody levels may have dropped enough to produce a false negative.
There’s one important catch. About 2% to 3% of people are deficient in IgA, the type of antibody these tests measure. If you’re IgA deficient, the standard celiac test can miss the disease entirely. Doctors who suspect celiac in a patient with a negative result will often check total IgA levels to see if deficiency explains the negative finding. If it does, IgG-based versions of the same test can fill in the gap. A small intestinal biopsy remains the gold standard for confirming celiac disease when blood results are ambiguous.
When Blood Tests Aren’t Enough
Some autoimmune diseases can’t be fully diagnosed with blood work alone. Imaging plays a growing role in catching autoimmune conditions early, sometimes before symptoms become obvious. MRI can detect inflammation in joints, organs, and blood vessels that hasn’t yet caused noticeable damage. CT scans help visualize structural changes in tissues and can guide biopsy procedures when a tissue sample is needed.
Biopsies are essential for certain diagnoses. Lupus affecting the kidneys, for example, is graded by kidney biopsy, and the severity found on biopsy heavily influences treatment decisions. Celiac disease often requires a small bowel biopsy for confirmation. Skin biopsies can help distinguish autoimmune skin conditions from other causes. Muscle biopsies may be needed for inflammatory myopathies when antibody tests are inconclusive.
What to Expect From the Process
If your doctor suspects autoimmune disease, the typical starting point is a combination of ANA, CRP, ESR, and a complete blood count. Based on those results and your symptoms, you may be referred to a specialist, usually a rheumatologist for joint and connective tissue diseases, an endocrinologist for thyroid conditions, or a gastroenterologist for celiac disease. From there, more targeted antibody panels narrow the diagnosis.
Expect the process to take time. Autoimmune symptoms often overlap, and early-stage disease may not produce clear lab results. It’s common for initial tests to come back borderline or inconclusive, requiring repeat testing months later as the disease evolves. Keeping a written log of your symptoms, including when they started, what makes them worse, and how they change over time, gives your doctor more to work with than any single blood draw can.